Eton Pharmaceuticals Relaunches HEMANGEOL for Infants
DEER PARK, Illinois, May 1, 2026 Eton Pharmaceuticals, Inc. announced the relaunch of HEMANGEOL® (propranolol) oral solution, the only...
FDA approved therapy
Advertisement
Tenvie Therapeutics Doses First Patient in TNV262 Trial
Brisbane, California, USA, April 6, 2026 First-in-Human Study Targets Inflammation Pathways In a significant milestone for clinical-stage biotech innovation,...
Neurocrine Acquires Soleno to Boost Rare Disease Portfolio
San Diego & Redwood City, California, USA, April 6, 2026 Strategic Acquisition Strengthens Rare Disease Leadership In a major...
Talicia U.S. Commercialization Launch Expands Reach
February 25, 2026 – Raleigh, North Carolina & Tel-Aviv, Israel RedHill Biopharma Ltd. has announced the full operational and...
BridgeBio Secures $300 Million Upfront Through Royalty Monetization of BEYONTTRA in Europe
PALO ALTO, CA., June 30, 2025 — BridgeBio Pharma, Inc. (Nasdaq: BBIO), the biopharmaceutical company dedicated to developing transformative...
Advertisement
